PharVision Advisers’s Teekay TK Stock Holding History

PharVision Advisers’s Portfolio TK Stock Details TK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,651	Closed	-$96.2K	–	597
2025 Q4	$96.2K	Sell	10,651 -1,184	-10%	-$10.9K	0.05%	658
2025 Q3	$96.8K	Buy	+11,835	New	+$94.2K	0.05%	626
2025 Q1	–	Sell	-10,871	Closed	-$75.3K	–	508
2024 Q4	$75.3K	Buy	+10,871	New	+$83.8K	0.06%	378

Other funds holding TK

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FFL

Flat Footed LLC Wilson, Wyoming $920M AUM 86.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PharVision Advisers's TK Position: Q1 2026 in Review

PharVision Advisers sold out of Teekay (TK) in Q1 2026, closing a stake of 10,651 shares — an estimated $96.2K sold.

PharVision Advisers first reported a position in TK in Q4 2024 and held it in 3 quarters. The position peaked at $96.8K in Q3 2025. 187 funds tracked by Wall St. Rank hold TK as of Q1 2026.

PharVision Advisers reported no remaining Teekay position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 10,651 Teekay shares in Q1 2026, an estimated $96.2K.
PharVision Advisers first reported a position in Teekay in Q4 2024 and held it in 3 quarters.
PharVision Advisers's Teekay position peaked at $96.8K in Q3 2025.
187 funds tracked by Wall St. Rank held Teekay as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.